Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 24
Phase 31

Trial Status

Completed1
Recruiting2
Other2

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT06500676Phase 1/2Recruiting
A Study of GFH375 in Patients With Advanced Solid Tumors With KRAS G12D Mutations
Advanced Solid TumorsKRAS G12D Mutations
PrincipalinvestigatorStart date: 2024-07-09
NCT04837508Phase 2Unknown
A Study of MRG002 in the Treatment of HER2-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer
Advanced or Metastatic Biliary Tract Cancer
PrincipalinvestigatorStart date: 2021-06-07
NCT04838964Phase 2Completed
A Study of MRG003 in the Treatment of EGFR-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer
Advanced or Metastatic Biliary Tract Cancer
PrincipalinvestigatorStart date: 2021-05-18
NCT04839510Phase 2Unknown
A Study of MRG002 in the Treatment of HER2-positive Unresectable Locally Advanced or Metastatic Urothelium Cancer
Locally Advanced Urothelial CancerMetastatic Urothelial Carcinoma
PrincipalinvestigatorStart date: 2021-04-20

Research Network

Collaboration Network

8 collaborators·7 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT06500676Phase 1/2PrincipalInvestigator

A Study of GFH375 in Patients With Advanced Solid Tumors With KRAS G12D Mutations

Advanced Solid TumorsKRAS G12D Mutations
Recruiting
NCT04837508Phase 2PrincipalInvestigator

A Study of MRG002 in the Treatment of HER2-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer

Advanced or Metastatic Biliary Tract Cancer
Unknown
NCT04838964Phase 2PrincipalInvestigator

A Study of MRG003 in the Treatment of EGFR-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer

Advanced or Metastatic Biliary Tract Cancer
Completed
NCT04839510Phase 2PrincipalInvestigator

A Study of MRG002 in the Treatment of HER2-positive Unresectable Locally Advanced or Metastatic Urothelium Cancer

Locally Advanced Urothelial CancerMetastatic Urothelial Carcinoma
Unknown
NCT05754853Phase 3PrincipalInvestigator

A Study of MRG002 Versus Investigator's Choice of Chemotherapy in the Treatment of Patients With HER2-positive Unresectable Advanced or Metastatic Urothelial Cancer

Advanced or Metastatic Urothelium Cancer
Recruiting

All 5 trials loaded